124 related articles for article (PubMed ID: 77180)
1. Treatment of advanced Hodgkin's disease with B-CAVE following MOPP failure.
Porzig KJ; Portlock CS; Robertson A; Rosenberg SA
Cancer; 1978 May; 41(5):1670-5. PubMed ID: 77180
[TBL] [Abstract][Full Text] [Related]
2. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy.
Krikorian JG; Portlock CS; Rosenberg SA
Cancer; 1978 Jun; 41(6):2107-11. PubMed ID: 77716
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
Piga A; Ambrosetti A; Todeschini G; Cetto G; Perona G; Cellerino R
Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
[TBL] [Abstract][Full Text] [Related]
5. New multiple-agent chemotherapy (B-DOPA) for advanced Hodgkin's disease.
Lokich JJ; Frei E; Jaffe N; Tullis J
Cancer; 1976 Aug; 38(2):667-71. PubMed ID: 61797
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial.
Duggan DB; Petroni GR; Johnson JL; Glick JH; Fisher RI; Connors JM; Canellos GP; Peterson BA
J Clin Oncol; 2003 Feb; 21(4):607-14. PubMed ID: 12586796
[TBL] [Abstract][Full Text] [Related]
7. Combination chemotherapy for advanced Hodgkin's disease after failure of MOPP: ABVD and B-CAVe.
Harker WG; Kushlan P; Rosenberg SA
Ann Intern Med; 1984 Oct; 101(4):440-6. PubMed ID: 6206757
[TBL] [Abstract][Full Text] [Related]
8. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)].
Osieka R; Bruntsch U; Gallmeier WM; Seeber S; Schmidt CG
Dtsch Med Wochenschr; 1976 Aug; 101(32):1177-82. PubMed ID: 59661
[TBL] [Abstract][Full Text] [Related]
9. The treatment of advanced hodgkin's disease.
Straus DJ; Lee BJ; Koziner B; Nisce LZ; Young CW; Clarkson BD
Blut; 1981 Aug; 43(2):119-24. PubMed ID: 6167303
[TBL] [Abstract][Full Text] [Related]
10. Prolonged disease-free survival in MOPP-resistant Hodgkin's disease after treatment with adriamycin, bleomycin, vinblastine and dacarbazine (ABVD).
Santoro A; Bonadonna G
Cancer Chemother Pharmacol; 1979; 2(2):101-5. PubMed ID: 93984
[TBL] [Abstract][Full Text] [Related]
11. Combination chemotherapy of MOPP-resistant Hodgkin's disease with adriamycin, bleomycin, dacarbazine and vinblastine (ABDV).
Case DC; Young CW; Lee BJ
Cancer; 1977 Apr; 39(4):1382-6. PubMed ID: 66972
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of advanced Hodgkin's disease patients treated with a combination of streptozotocin, lomustine (CCNU), doxorubicin and bleomycin (SCAB).
Wiernik PH; Schiffer CA
J Cancer Res Clin Oncol; 1988; 114(1):105-7. PubMed ID: 2450876
[TBL] [Abstract][Full Text] [Related]
13. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Santoro A; Viviani S; Valagussa P; Bonfante V; Bonadonna G
Semin Oncol; 1986 Mar; 13(1 Suppl 1):23-6. PubMed ID: 2420012
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP.
Bonadonna G; Zucali R; Monfardini S; De Lena M; Uslenghi C
Cancer; 1975 Jul; 36(1):252-9. PubMed ID: 54209
[TBL] [Abstract][Full Text] [Related]
15. Randomized study for the treatment of adult advanced Hodgkin's disease: mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) versus lomustine, vinblastine, and prednisone.
Liebman HA; Hum GJ; Sheehan WW; Ryden VM; Bateman JR
Cancer Treat Rep; 1983 May; 67(5):413-9. PubMed ID: 6342771
[TBL] [Abstract][Full Text] [Related]
16. Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPP.
Santoro A; Viviani S; Villarreal CJ; Bonfante V; Delfino A; Valagussa P; Bonadonna G
Cancer Treat Rep; 1986 Mar; 70(3):343-8. PubMed ID: 2420444
[TBL] [Abstract][Full Text] [Related]
17. MOPP treatment of resistant Hodgkin's disease following ABVD failure.
Cimino G; Anselmo AP; Marzullo A; Maurizi Enrici R; Mauro F; Papa G; Mandelli F
Tumori; 1983 Oct; 69(5):469-72. PubMed ID: 6196891
[TBL] [Abstract][Full Text] [Related]
18. ABVD treatment of MOPP failures in Hodgkin's disease: a re-examination of goals of salvage therapy.
Clamon GH; Corder MP
Cancer Treat Rep; 1978 Mar; 62(3):363-7. PubMed ID: 77188
[No Abstract] [Full Text] [Related]
19. Third-line salvage chemotherapy in Hodgkin's disease.
Bonadonna G; Viviani S; Valagussa P; Bonfante V; Santoro A
Semin Oncol; 1985 Mar; 12(1 Suppl 2):23-5. PubMed ID: 2579440
[TBL] [Abstract][Full Text] [Related]
20. Cyclophosphamide, vinblastine, procarbazine and prednisone with CCNU and vinblastine maintenance for advanced Hodgkin's disease.
Diggs CH; Wiernik PH; Levi JA; Kvols LK
Cancer; 1977 May; 39(5):1949-54. PubMed ID: 870162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
